Abstract:Parkinson's disease is a progressive degenerative nervous system disease. Recent studies have shown that secondary changes in the GABA system play directly affect the pathogenesis of PD. There is still much debate about GABA concentrations because currently, GABA concentrations in the brain tissue are obtained indirectly by measuring its concentration in the blood and cerebrospinal fluid. These results are unreliable. Magnetic resonance spectroscopy (MRS) is the only noninvasive method for evaluating the concentration of metabolites in living brain tissue and has been widely applied in research and clinical practice. In addition, combining MEGA-PRESS technology with LCModel software for quantitative GABA measurements is largely recognized. At present, the PD monkeys model in primates has been increasingly proficient. Primates are more similar to humans in terms of brain structure and function than other animals. However, 3.0 T MRS studies involving the PD monkey model to measure metabolites in living subjects with PD are still rare. The study was performed at 3.0 T MRI with control monkeys and PD monkeys that were injected methyl-phenyl-tetrahydropyridine (MPTP) in one side of common carotid artery before and 3 months after successful model establishment to measure GABA concentrations in the bilateral striatum. Behavioral observations were performed for all animals, and the behavioral score was recorded. After 3 months, the GABA concentration in the bilateral striatum was measured in both groups by high-performance liquid chromatography (HPLC). The data obtained from magnetic resonance spectroscopy (MRS) were compared with the actual measured GABA concentrations in tissues isolated from the corresponding regions, and their correlations with the behavior score were analyzed. The research objectives are to investigate the changes of γ-aminobutyric acid (GABA) concentration in the bilateral striatum of monkeys with Parkinson's disease (PD) and the value of quantitatively measuring its concentration by noninvasive 3.0 T spectroscopy. (1) The MRS results showed that the GABA concentration in the injured side of the striatum of the PD monkeys was higher than in the contralateral side, but the difference was not statistically significant (P = 0.154). Compared with that the blank control group, the GABA concentration in the striatum of the PD monkeys increased, but there was no difference between the groups (P = 0.381; P = 0.425). (2) The GABA concentration that determined from the isolated specimens by HPLC in the injured side of the striatum of the PD monkeys was significantly higher than that in the contralateral side (P < 0.01). Compared with the blank control group, the PD monkeys had higher GABA concentrations in both sides of the striatum, and there was a significant difference in the lesion side (P = 0.004), while there was a non-significant difference in the contralateral side (P = 0.475). (3) The mean GABA concentration in the injured striatum of PD monkeys determined by MRS was not significantly correlated with the behavioral score (r = 0.146, P = 0.688). The mean GABA concentration in the injured striatum determined from the isolated specimens was positively correlated with the behavioral score in the same period (r = 0.444, P = 0.038). The GABA concentration in the injured striatum of PD monkeys is increased and positively correlated with behavioral changes. Validity of noninvasive 3.0 T MRS to detect PD neurotransmitter changes is limited.

Comparative Study of Striatum GABA Concentrations and Magnetic Resonance Spectroscopic Imaging in Parkinson's Disease Monkeys

Magnetic resonance spectroscopy imaging of medulla oblongata and substantia nigra in idiopathic Parkinson's disease

1H-MRS in Observation of Metabolism of Medulla Oblongata and Substantia Nigra in Parkinson Disease

Parkinson׳s Disease-Related Modulation of Functional Connectivity Associated with the Striatum in the Resting State in a Nonhuman Primate Model

Comparative Imaging Study on Monkeys with Hemi-Parkinsonism

Application of Proton Magnetic Resonance Spectroscopy on Substantia Nigra Metabolites in Parkinson’s Disease

[Comparison of Parkinson's Monkey Models Induced by Unilateral and Bilateral Intracerebroventricular Injections of MPP].

Proton Magnetic Resonance Spectroscopic Changes in the Striatum in Rat Model of Parkinson's Disease

[Changes of Glucose in the Brains of Monkeys with MPTP Induced Parkinson's Disease].

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

The Role of Iron in Parkinson's Disease Monkeys Assessed by Susceptibility Weighted Imaging and Inductively Coupled Plasma Mass Spectrometry.

Progressive Loss of Striatal Dopamine Terminals in MPTP-induced Acute Parkinsonism in Cynomolgus Monkeys Using Vesicular Monoamine Transporter Type 2 PET Imaging ([ 18 F]AV-133)

Changes and Significance Proton Magnetic Resonance Spectroscopy in Parkinson′s Disease Patients

Comparative Study of Bilateral Putamen for Patients with Severe Parkinson's Disease Detected by 1H Magnetic Resonance Spectroscopy

Evaluation of the Braak Staging of Brain Pathology with 1H-MRS in Patients with Parkinson’s Disease

Retracted: 1h-Mrs Can Monitor Metabolites Changes Of Lateral Intraventricular Bdnf Infusion Into A Mouse Model Of Alzheimer'S Disease In Vivo(Retracted Article. See Vol. 254, Pg. 477, 2013)

Quantification of Non-Motor Symptoms in Parkinsonian Cynomolgus Monkeys

Detection and Application of Neurochemical Profile by Multiple Regional 1H‐MRS in Parkinson's Disease

SPECT Imaging of Dopamine Transporter in Monkey Model of Chronic Parkinson's Disease

Retracted: 1H-MRS Can Monitor Metabolites Changes of Lateral Intraventricular BDNF Infusion into a Mouse Model of Alzheimer’s Disease in Vivo [neuroscience 245 (2013) 40–49]

~1H-MRS Evaluation of Metabolism among Different Regions of Brain in Parkinson's Disease Patients